États-Unis · Plateformes & données · MarketBeat

Takeda Pharmaceutical (NYSE:TAK) Releases Quarterly Earnings Results, Beats Expectations By $0.37 EPS

Publié par MarketBeat · États-Unis il y a 2 h

Takeda Pharmaceutical (NYSE:TAK - Get Free Report) posted its earnings results on Thursday. The company reported $0.51 EPS for the quarter, topping analysts' consensus estimates…

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Takeda Pharmaceutical (NYSE:TAK) Releases Quarterly Earnings Results, Beats Expectations By $0.37 EPS

À lire aussi

These 3 Big Risks Could Cause the Next Bear Market. I'm Investing Anyway.

WisdomTree outlines plan to launch 15 to 20 Atlantic House products over 18 to 24 months as Onchain platform expands partnerships

In a wild October for markets, these stocks were the biggest winners and losers

Akari Therapeutics shareholders approve increase in shares for 2023 equity plan

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Cathie Wood's Ark warns of growing threat after Binance hack

Takeda Pharmaceutical (NYSE:TAK) Releases Quarterly Earnings Results, Beats Expectations By $0.37 EPS

Partager

À lire aussi

These 3 Big Risks Could Cause the Next Bear Market. I'm Investing Anyway.

WisdomTree outlines plan to launch 15 to 20 Atlantic House products over 18 to 24 months as Onchain platform expands partnerships

In a wild October for markets, these stocks were the biggest winners and losers

Akari Therapeutics shareholders approve increase in shares for 2023 equity plan

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Cathie Wood's Ark warns of growing threat after Binance hack